Exome Asset Management LLC
Filing Date
Global Rank
#4,571
/ 8,622
▼ 208
· as of Mar 2026
Top Industry
Biotechnology
71.3%
3Y Alpha vs SPY
+15.8%
Period ended 4 months ago
Filed May 15, 2026 · 2mo
10 quarters · since Dec 2023
Clone Performance
Feb 2024–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Cloned portfolio
+107.5%
SPY
+52.7%
Annualised alpha
+15.8%
Max drawdown
−33.0%
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 10 quarters. Past performance does not predict future results.
Portfolio Concentration
45 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
8.6%
−0.1 pts
Top 5
29.4%
+1.1 pts
Top 10
46.5%
+1.1 pts
HHI
340
Diversified+24
Portfolio Trend
10 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $169,964,515 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
4 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VSTM | Verastem, Inc. | +234,957 | 636,700 | $3,374,510 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | +94,593 | 234,136 | $2,198,537 | |
| NBP | NovaBridge Biosciences | +77,373 | 576,960 | $1,419,321 | |
| UNH | Unitedhealth Group Inc | +7,027 | 12,862 | $3,480,328 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
23 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ADAG | Adagene Inc. | −323,376 | 736,845 | $2,888,432 | |
| CTMX | CytomX Therapeutics, Inc. | −223,837 | 521,468 | $2,450,899 | |
| PALI | Palisade Bio, Inc. | −158,203 | 600,000 | $1,050,000 | |
| APLS | Apellis Pharmaceuticals, Inc. | −50,332 | 85,517 | $3,440,348 | |
| NXTC | NextCure, Inc. | −49,500 | 115,500 | $1,233,540 | |
| LQDA | Liquidia Corp | −45,352 | 45,796 | $1,728,341 | |
| COGT | Cogent Biosciences, Inc. | −27,035 | 278,533 | $10,720,735 | |
| CYTK | Cytokinetics Inc | −21,031 | 103,718 | $6,836,053 | |
| GH | Guardant Health, Inc. | −15,446 | 82,736 | $7,642,324 | |
| BBIO | BridgeBio Pharma, Inc. | −13,231 | 67,492 | $5,011,955 | |
| ALMS | Alumis Inc. | −13,074 | 279,176 | $6,150,247 | |
| PRAX | Praxis Precision Medicines, Inc. | −12,653 | 45,469 | $14,649,657 | |
| AGIO | Agios Pharmaceuticals, Inc. | −11,882 | 125,060 | $4,230,779 | |
| GKOS | GLAUKOS Corp | −10,597 | 20,874 | $2,247,294 | |
| TXG | 10x Genomics, Inc. | −9,464 | 154,194 | $3,273,538 | |
| VERA | Vera Therapeutics, Inc. | −9,400 | 114,991 | $4,626,087 | |
| IONS | Ionis Pharmaceuticals Inc | −6,451 | 110,064 | $8,264,705 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | −4,037 | 45,721 | $2,866,706 | |
| PEN | Penumbra Inc | −2,700 | 6,300 | $2,068,731 | |
| ELV | Elevance Health, Inc. | −2,514 | 14,677 | $4,296,691 | |
| ELVN | Enliven Therapeutics, Inc. | −2,217 | 220,091 | $8,627,567 | |
| LLY | ELI LILLY & Co | −840 | 7,012 | $6,449,427 | |
| UTHR | UNITED THERAPEUTICS Corp | −632 | 7,053 | $4,182,287 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
14 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| INSM | INSMED Inc | 26,651 | $4,357,971 | |
| MLTX | MoonLake Immunotherapeutics | 215,376 | $4,014,608 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 40,581 | $3,529,329 | |
| BSX | Boston Scientific Corp | 48,347 | $3,033,774 | |
| ALKS | Alkermes plc. | 84,103 | $2,973,882 | |
| GLUE | Monte Rosa Therapeutics, Inc. | 179,484 | $2,952,511 | |
| CBIO | Crescent Biopharma, Inc. | 153,191 | $2,814,118 | |
| RLAY | Relay Therapeutics, Inc. | 278,302 | $2,769,104 | |
| MAZE | Maze Therapeutics, Inc. | 88,510 | $2,642,023 | |
| AVTX | Avalo Therapeutics, Inc. | 159,341 | $2,378,961 | |
| SLNO | Soleno Therapeutics Inc | 61,673 | $2,064,812 | |
| ZBIO | Zenas BioPharma, Inc. | 80,730 | $1,578,271 | |
| FDMT | 4D Molecular Therapeutics, Inc. | 130,564 | $1,215,550 | |
| LPCN | Lipocine Inc. | 60,861 | $486,279 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
20 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | 421,488 | $7,165,296 | |
| JAZZ | Jazz Pharmaceuticals plc | 26,494 | $4,503,980 | |
| IMVT | Immunovant, Inc. | 158,622 | $4,032,171 | |
| UHS | Universal Health Services Inc | 17,628 | $3,843,256 | |
| IRON | Disc Medicine, Inc. | 46,743 | $3,711,861 | |
| CELC | Celcuity Inc. | 34,289 | $3,419,984 | |
| TVTX | Travere Therapeutics, Inc. | 89,052 | $3,402,676 | |
| DXCM | Dexcom Inc | 50,147 | $3,328,256 | |
| IMCR | Immunocore Holdings plc | 76,750 | $2,663,992 | |
| EWTX | Edgewise Therapeutics, Inc. | 100,046 | $2,482,641 | |
| BLTE | Belite Bio, Inc | 14,328 | $2,291,906 | |
| WAY | Waystar Holding Corp. | 68,969 | $2,258,734 | |
| IRWD | Ironwood Pharmaceuticals Inc | 648,532 | $2,185,552 | |
| KPTI | Karyopharm Therapeutics Inc. | 295,541 | $2,175,181 | |
| UPB | Upstream Bio, Inc. | 64,845 | $1,760,541 | |
| GOSS | Gossamer Bio, Inc. | 451,699 | $1,400,266 | |
| IKT | Inhibikase Therapeutics, Inc. | 600,000 | $1,230,000 | |
| IQV | Iqvia Holdings Inc. | 5,378 | $1,212,254 | |
| THC | Tenet Healthcare Corp | 6,084 | $1,209,012 | |
| FULC | Fulcrum Therapeutics, Inc. | 92,055 | $1,041,142 | |
| No positions match the current search. | ||||
45 tracked positions ·
$169,964,515 total
· filing declares
56 positions · $193,345,271
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 45,469 | $14,649,657 | 8.62% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 278,533 | $10,720,735 | 6.31% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Reduced | 220,091 | $8,627,567 | 5.08% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Reduced | 110,064 | $8,264,705 | 4.86% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Reduced | 82,736 | $7,642,324 | 4.50% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 103,718 | $6,836,053 | 4.02% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 7,012 | $6,449,427 | 3.79% | |
| ALMS |
Alumis Inc.
Healthcare
|
Reduced | 279,176 | $6,150,247 | 3.62% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 67,492 | $5,011,955 | 2.95% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 114,991 | $4,626,087 | 2.72% | |
| INSM |
INSMED Inc
Healthcare
|
NEW | 26,651 | $4,357,971 | 2.56% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Reduced | 14,677 | $4,296,691 | 2.53% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Reduced | 125,060 | $4,230,779 | 2.49% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 7,053 | $4,182,287 | 2.46% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
NEW | 215,376 | $4,014,608 | 2.36% | |
| NTRA |
Natera, Inc.
Healthcare
|
Held | 18,650 | $3,729,813 | 2.19% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
NEW | 40,581 | $3,529,329 | 2.08% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 12,862 | $3,480,328 | 2.05% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 85,517 | $3,440,348 | 2.02% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Added | 636,700 | $3,374,510 | 1.99% | |
| TXG |
10x Genomics, Inc.
Healthcare
|
Reduced | 154,194 | $3,273,538 | 1.93% | |
| BSX |
Boston Scientific Corp
Healthcare
|
NEW | 48,347 | $3,033,774 | 1.78% | |
| ALKS |
Alkermes plc.
Healthcare
|
NEW | 84,103 | $2,973,882 | 1.75% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
NEW | 179,484 | $2,952,511 | 1.74% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Held | 6,358 | $2,930,974 | 1.72% | |
| ADAG |
Adagene Inc.
Healthcare
|
Reduced | 736,845 | $2,888,432 | 1.70% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Reduced | 45,721 | $2,866,706 | 1.69% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
NEW | 153,191 | $2,814,118 | 1.66% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
NEW | 278,302 | $2,769,104 | 1.63% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
NEW | 88,510 | $2,642,023 | 1.55% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Reduced | 521,468 | $2,450,899 | 1.44% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
NEW | 159,341 | $2,378,961 | 1.40% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Reduced | 20,874 | $2,247,294 | 1.32% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
Added | 234,136 | $2,198,537 | 1.29% | |
| PEN |
Penumbra Inc
Healthcare
|
Reduced | 6,300 | $2,068,731 | 1.22% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
NEW | 61,673 | $2,064,812 | 1.21% | |
| LQDA |
Liquidia Corp
Healthcare
|
Reduced | 45,796 | $1,728,341 | 1.02% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
NEW | 80,730 | $1,578,271 | 0.93% | |
| NBP |
NovaBridge Biosciences
Healthcare
|
Added | 576,960 | $1,419,321 | 0.84% | |
| NXTC |
NextCure, Inc.
Healthcare
|
Reduced | 115,500 | $1,233,540 | 0.73% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
NEW | 130,564 | $1,215,550 | 0.72% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Reduced | 600,000 | $1,050,000 | 0.62% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
Held | 13,100 | $743,818 | 0.44% | |
| LPCN |
Lipocine Inc.
Healthcare
|
NEW | 60,861 | $486,279 | 0.29% | |
| ABUS |
Arbutus Biopharma Corp
Healthcare
|
Held | 75,484 | $339,678 | 0.20% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.